Skip to main content

Publications

Below are the 50 most recent publications by faculty members in the Department of Neurology at Northwestern University Feinberg School of Medicine.

  1. Air EL, Ryschon AM, Rosenow JM, Garner AM, Levin RW, Konrad PE, Pietzsch JB  Cost-effectiveness of vagus nerve-mediated neuroimmune modulation for the treatment of moderate-to-severe rheumatoid arthritis.  J Med Econ  2026 Dec;29(1):1462-1473. doi:10.1080/13696998.2026.2662122
  2. Zhang C, Wang R, Capal JK, Srivastava S, Filip-Dhima R, Bebin EM, Krueger DA, Northrup H, Wu JY, Warfield SK  et al.  A two-step temporal data augmentation and supervised learning framework for predicting autism diagnosis at 36 months in patients with tuberous sclerosis complex.  Comput Biol Med  2026 Jul 01;210:111719. doi:10.1016/j.compbiomed.2026.111719
  3. Hasan N, Zarnegar A, Nouri H, Saju S, Cao J, Zhou A, Wykoff C, Shah P, Singhanetr P, Rossin EJ  et al.  ELLIPSOID ZONE INTEGRITY AT ANGIOGRAPHIC LEAK AFTER RESOLUTION OF CENTRAL SEROUS CHORIORETINOPATHY: MICRoN Report Number Two.  Retina  2026 Jul 01;46(7):1272-1281. doi:10.1097/IAE.0000000000004811
  4. Head W, Kalsotra S, Yu M, Shannon K, Edwards P, Renshaw S, Arhos E, Wei L, Di Stasi S, Chaudhari A  et al.  Functional Status after Ventral Hernia Repair: Longitudinal Trends and the Limits of Improvement.  J Am Coll Surg  2026 Jul 01;243(1):60-69. doi:10.1097/XCS.0000000000001910
  5. Wolkiewicz L, Okematti E, Ghandour D, Guo K, Gerard EE, Nathan CL  EEG and MRI Correlate of Aphasia in a Patient With Thrombotic Thrombocytopenic Purpura.  Neurology  2026 Jun 23;106(12):e218092. doi:10.1212/WNL.0000000000218092
  6. Archer G, Bernanke A, Hollenhorst CN, Yu M, Schnipke B, Gershan S  Barbiturates for the Management of Gamma-Hydroxybutyrate (GHB) Withdrawal: A Systematic Review.  J Psychoactive Drugs  2026 Jun 17;:1-25. doi:10.1080/02791072.2026.2686369
  7. Dos Santos M, Forrest MP, Bomba-Warczak E, Dey S, Parnell E, Christiansen JM, Edassery SL, Yang K, Hayes LN, Coughlin JM  et al.  Soluble α2δ-1, altered in disease CSF, modulates network homeostasis and rescues deficits in a neuropsychiatric mouse model.  Neuron  2026 Jun 17;114(12):2128-2147.e10. doi:10.1016/j.neuron.2026.02.004
  8. Silva Pinheiro do Nascimento J, Copenhaver K, Garg R, Goldenberg F, Chang T, Shownkeen H, Faine B, Lindholm PF, Grotta J, Naidech AM  Minimal Fibrinolysis After Acute Intracerebral Hemorrhage Undercuts the Mechanism of Tranexamic Acid.  J Am Heart Assoc  2026 Jun 16;15(12):e049124. doi:10.1161/JAHA.125.049124
  9. Pacifico P, George D, Jayaraj ND, Ren D, Coy-Dibley JS, Belmadani AA, Veronesi S, Andelic M, Cartelli D, Devigili G  et al.  Skin-resident Langerhans cells drive neuropathic pain via chemokine-dependent neuron-immune communication.  J Clin Invest  2026 Jun 15;136(12). pii:e192328
  10. Lastra AC, Wolfe LF, Mokhlesi B  Unexplained hypoventilation in adults: autoimmune encephalitis and beyond.  Eur Respir J  2026 Jun;67(6). pii:2600454
  11. Vogeley A, Russell A, Yeh F, Curtis L, Opsasnick L, Yoshino Benavente J, Bonham M, Lovett R, Light SW, Sun B  et al.  Prevalence of Limited Health Literacy During Middle Adulthood and Its Associations with Health Self-Management and Physical Function.  J Gen Intern Med  2026 Jun 10;. doi:10.1007/s11606-026-10560-x
  12. Sadeghi E, Peng L, Lall SR, Hasan N, Williamson RC, Chotcomwongse P, Ruamviboonsuk P, Lupidi M, Munk MR, Kim M  et al.  Radiomics-based fundus autofluorescence analysis in central serous chorioretinopathy-MICRoN report number twelve.  Sci Rep  2026 Jun 10;. doi:10.1038/s41598-026-56995-4
  13. Ozlu C, Schwaede A, McGowan B, Zhang L, Finch M, Wolfe LF, Ajroud-Driss S, Franz CK, Kuntz N  Two Patients With Juvenile-Onset, Rapidly Progressive Amyotrophic Lateral Sclerosis Associated With an SOD1 Variant (p.Asp125Gly) With Incomplete Penetrance.  Muscle Nerve  2026 Jun 09;. doi:10.1002/mus.70314
  14. Khorasani A, Gorski CM, Hung NT, Hulsizer J, Paul V, Tomic G, Prakash PR, Park S, Seo G, Houskamp EJ  et al.  Wearable Myoelectric Interface for Neurorehabilitation (MINT) to Recover Arm Activity After Stroke: A Randomized Controlled Trial.  Neurorehabil Neural Repair  2026 Jun 08;:15459683261454937. doi:10.1177/15459683261454937
  15. Citro S, Dawson MS, Beyh A, Dell'Acqua F, Cavaliere C, Dyrby TB, Krug K, Ptito M, Carnevale L, Della Sala S  et al.  Evolution of the frontal aslant tract and implications for primate vocalization and human speech.  Nat Commun  2026 Jun 06;. doi:10.1038/s41467-026-73731-8
  16. Vesevick DR, Ghosh S, Kalmes A, Ozdinler PH, Gautam M  Neuroprotective Effects of RNS60 in TDP-43 Pathology-Associated Amyotrophic Lateral Sclerosis.  Muscle Nerve  2026 Jun 04;. doi:10.1002/mus.70289
  17. Sadleir KR, Gomez KP, Chandra S, Ley ML, Khatri AW, Guo J, Xue Y, Cepko CL, Vassar R  Neuronal overexpression of Nrf2 reduces dystrophic neurites in 5XFAD Alzheimer's disease model mice.  Alzheimers Res Ther  2026 Jun 03;. doi:10.1186/s13195-026-02097-2
  18. Li J, Wang X, Tong L, Feng B, Shih LK, Markwell SM, Nuszen H, Gruchala T, Lam NG, Basakis P  et al.  The Peri-necrotic Niche of Glioblastoma Drives Tumor-associated Macrophage Polarization and Immunosuppression via Podoplanin-mediated CLEC5A Activation.  J Clin Invest  2026 Jun 02;. pii:e199228
  19. Li N, Gao Q, Jia H, Xue G, Zhou Y, Wang S, Ma S, Hu B, Zhao Z, Su C  et al.  SIRT2-mediated deacetylation activates USP22 catalytic function for PD-L1 protein stabilization and tumor immune escape.  J Clin Invest  2026 Jun 02;. pii:e198270
  20. Habashy KJ, Arrieta VA, Haupt B, Gómez M, El-Hajj VG, Kim KS, Dmello C, Chen L, Carpentier A, Canney M  et al.  Development of skull-implanted ultrasound for blood-brain barrier opening and drug delivery in neuro-oncology.  Neurooncol Adv  2026 Jun;8(Suppl 4):iv9-iv19. doi:10.1093/noajnl/vdaf044
  21. Kim M, Reid KJ, Friedlander R, Grobman WA, Wolf MS, Facco F, Silver RM, Greenland P, Yee LM, Zee PC  Initiation of first-generation antihistamines during pregnancy and gestational restless legs syndrome: a secondary analysis of the nuMoM2b cohort.  Am J Obstet Gynecol MFM  2026 Jun;8(6):101940. doi:10.1016/j.ajogmf.2026.101940
  22. Minogue G, Zouridakis A, Nelson C, Kawles A, Keszycki R, Macomber A, Weintraub S, Gill N, Mao Q, Jamshidi P  et al.  Syndrome-specific vulnerability of neuronal and glial 4-repeat frontotemporal lobar degeneration-tau.  Brain  2026 Jun 01;. pii:awag190
  23. Menozzi E, Toffoli M, Deleidi M, Di Monte DA, Blandini F, Krainc D, Sidransky E, Schapira AHV  New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment.  Lancet Neurol  2026 Jun;25(6):602-614. doi:10.1016/S1474-4422(26)00090-6
  24. Dalal V, Zhou Y, Deb DK, Thomson BR, Nelson JW, Ledogar G, Misener S, Maekawa H, Chang A, Chung E  et al.  Transcription factor 21 deletion from podocyte precursors as a model for congenital nephrotic syndrome.  Am J Physiol Renal Physiol  2026 Jun 01;330(6):F746-F760. doi:10.1152/ajprenal.00490.2025
  25. Meletti S, Hanin A, Giovannini G, Bedin R, Burani M, Taruffi L, Orlandi N, Urbano T, D'Achille F, Malerba M  et al.  Acute Brain Injury in New-Onset Refractory Status Epilepticus and Etiology-Defined Status Epilepticus.  JAMA Neurol  2026 Jun 01;83(6):563-572. doi:10.1001/jamaneurol.2026.0865
  26. Mencacci NE, Minakaki G, Maroofian R, De Pace R, Paimboeuf A, Branco Fonseca T, Abramova T, Shannon P, Chitayat D, Magrinelli F  et al.  Pathogenic variants in BORCS5 cause a spectrum of neurodevelopmental and neurodegenerative disorders with lysosomal dysfunction.  J Clin Invest  2026 Jun 01;136(11). pii:e195336
  27. Queisi MM, Tomatsu S, Jacobs Z, Dada M, Wuppalapati SN, Posada F, Weller J, Wilken J, Hancock L, Penner I  et al.  Depression severity and discordance between fatigue patient-reported outcomes in people with multiple sclerosis.  Mult Scler Relat Disord  2026 Jun;110:107192. doi:10.1016/j.msard.2026.107192
  28. Lei T, Scheid MR, Flint RD, Glaser JI, Slutzky MW  Active dissociation of intracortical spiking and high gamma activity.  Nature  2026 Jun;654(8119):744-750. doi:10.1038/s41586-026-10331-y
  29. Sorenson E, Heitzman D, Lee I, Jang G, Elman L, Habib AA, Wymer J, Hayat G, Goutman SA, Fernandes JAM  et al.  Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament Analyses.  Muscle Nerve  2026 Jun;73(6):976-983. doi:10.1002/mus.70192
  30. Gregori G, Sahoo NK, Hasan N, Zarnegar A, Lupidi M, Zhang M, Wu L, Cao J, Piccoli G, Vujosevic S  et al.  Demography, Clinical Characteristics and Long-Term Outcomes of Central Serous Chorioretinopathy in Women. MICRoN Report Number Fourteen.  Am J Ophthalmol  2026 Jun;286:140-151. doi:10.1016/j.ajo.2026.02.039
  31. Sahoo NK, Hasan N, Jacob N, Cao J, Wykoff CC, Shah P, Singhanetr P, Rossin EJ, Desideri LF, Hertkorn F  et al.  Clinical Characteristics and Outcomes in Central Serous Chorioretinopathy With Subretinal Hyper-Reflective Material: MICRoN Report 6.  Am J Ophthalmol  2026 Jun;286:152-162. doi:10.1016/j.ajo.2026.02.037
  32. Sharma R, Tiwari R, Zhou Y, O'Sullivan J, Maekawa H, Borkowski GS, Bukaric H, An SY, Thorp EB, Chandel NS  et al.  Endothelial prolyl hydroxylase 3 mitigates maladaptive inflammation to promote post-ischemic kidney repair.  Kidney Int  2026 Jun;109(6):1173-1187. doi:10.1016/j.kint.2026.01.017
  33. Maas MB  Abnormal sleep during acute illness: Therapeutic opportunity or allostatic phenomenon.  J Hosp Med  2026 Jun;21(6):687-688. doi:10.1002/jhm.70246
  34. Banker M, do Nascimento JSP, Shownkeen H, Chang TR, Goldenberg F, Faine B, Cella D, Schuele SU, Luo Y, Tipton E  et al.  Prophylactic Antiseizure Medication in Patients with Lobar Intracerebral Hemorrhage.  Neurocrit Care  2026 Jun;44(3):850-856. doi:10.1007/s12028-025-02423-w
  35. Sadagopan NS, Jain R, Chaliparambil RK, Khazanchi R, Rosenow JM, Potts MB, Chandler JP, Tate MC, Magill ST, Geynisman-Tan J  Sex Disparities in Normal Pressure Hydrocephalus Diagnosis and Urinary Outcomes.  Urogynecology (Phila)  2026 Jun 01;32(6):761-768. doi:10.1097/SPV.0000000000001737
  36. Nikolcheva T, Pagano G, Anzures-Cabrera J, Trundell D, Kustermann T, Simuni T, Marek K, Pavese N, Seppi K, Stocchi F  et al.  Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study.  Lancet  2026 May 30;407(10544):2227-2240. doi:10.1016/S0140-6736(26)00865-2
  37. Eldabe S, Nevitt S, Hunter CW, Rosenow JM, Maden M, Goudman L, Moens M, Kalia H, Soliday N, Leitner A  et al.  Response to: "Methodological limitations and conflicts of interest in spinal cord stimulation research impair trustworthiness".  Reg Anesth Pain Med  2026 May 29;. pii:rapm-2026-108122
  38. Vincze K, Szwajda A, Ploner A, Karlsson R, Kang X, Tang B, Qin C, Domenighetti C, Sugier PE, Ashok Kumar Sreelatha A  et al.  Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset.  NPJ Parkinsons Dis  2026 May 28;12(1). pii:127
  39. Piña Y, Umeh Garcia M, Boire A, Brenner A, Camidge DR, Chang S, Forsyth PA, Hayden Gephart M, Olayinka Kamson D, Kumthekar P  et al.  Breaking Barriers in Leptomeningeal Disease: A SNO-ASCO Consensus Review on Clinical Trial Design and Basic Science Integration.  Neuro Oncol  2026 May 27;. pii:noag126
  40. Lukas RV, Zhai L, Lauing KL, Kim M, Koch T, Penco-Campillo M, Bommi P, Dixit K, Kumthekar P, Sharp L  et al.  Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205.  Clin Cancer Res  2026 May 26;. doi:10.1158/1078-0432.CCR-26-1124
  41. Khani M, Yeboah SN, Cerquera-Cleves C, Kedmi A, Bustos BI, Grant SM, Can Akerman S, Akçimen F, Lee PS, Reyes-Pérez P  et al.  Is SORL1 a common genetic target across neurodegenerative diseases? A multi-ancestry biobank study.  Brain  2026 May 26;. pii:awag187
  42. Chung PA, Fleming VL, Reid KJ, Plante DT, Hom CL, Ances BM, Handen BL, Christian BT, Head E, Mapstone M  et al.  Circadian Rest-Activity Rhythms, Cognition, and Alzheimer Disease Dementia in Adults With Down Syndrome.  Neurology  2026 May 26;106(10):e214938. doi:10.1212/WNL.0000000000214938
  43. Hwang J, Cho SM, Johnson EL, Kimchi EY, Schuele SU, Habela CW, Ritzl EK  Typical and Atypical Frequency-Based Subtypes of EEG Reactivity in Hospitalized Patients and Association With Comorbidities and Outcomes.  Neurology  2026 May 26;106(10):e218034. doi:10.1212/WNL.0000000000218034
  44. Hasan N, Sahoo N, Gidwani K, Saju S, Cao J, Wykoff CC, Shah P, Singhanetr P, Rossin E, Ashfaq Y  et al.  Predictors of Good Visual Recovery in Patients With Spontaneously Resolved Acute CSCR - MICRoN Report Number Thirteen.  Am J Ophthalmol  2026 May 20;289:134-144. doi:10.1016/j.ajo.2026.05.023
  45. Mueller A, Vallejo V, Panadés MP, Hardiman O, Danel-Brunaud V, Ajroud-Driss S, Couratier P, Shefner J, Gokey A, DiCesare M  et al.  Evaluation of Digital Technologies for Home-Based Assessment in People With Amyotrophic Lateral Sclerosis.  Ann Clin Transl Neurol  2026 May 20;. doi:10.1002/acn3.70429
  46. Koerner J, Zou E, Karl JA, Poon C, Malkani RG, Verhagen Metman L, Sodini CG, Sze V, Heldt T, David FJ  iPad Eye Tracking Reproduces Clinical Grade Oculomotor Differences in Parkinson's Disease.  NPJ Digit Med  2026 May 19;. doi:10.1038/s41746-026-02753-9
  47. Gonzalez-Latapi P, Gochanour C, Choi SH, Cho H, Caspell-Garcia C, Coffey CS, Lafontant DE, Xiao Y, Tanner CM, Venuto CS  et al.  Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative.  Ann Neurol  2026 May 18;. doi:10.1002/ana.78248
  48. Zhang Z, van Olst L, Alessandrini F, Wright M, Edwards AJ, Boles J, Nalbandian A, Forsyth AV, Shepard N, Watson T  et al.  Integrated single-cell and spatial transcriptomic profiling in ALS uncovers peripheral-to-central immune infiltration and reprogramming.  Nat Neurosci  2026 May 14;. doi:10.1038/s41593-026-02300-5
  49. Kang X, Lin Z, Calikusu FZ, Miller LA, Soriano S, Locascio JJ, Corvol JC, Maple-Grødem J, Fan Y, Mead K  et al.  Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts.  NPJ Parkinsons Dis  2026 May 14;. doi:10.1038/s41531-026-01367-y
  50. Brown EG, Chahine LM, Dobkin RD, Simuni T, Foroud T, Heathers LEA, Tropea TF, Stanley CE, McMahon BA, Brüggemann N  et al.  Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative.  Ann Neurol  2026 May 14;. doi:10.1002/ana.78246

Follow Neurology on InstagramFacebookLinkedIn